Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China

@inproceedings{Zhang2017TriazoleRI,
  title={Triazole Resistance in Aspergillus fumigatus Clinical Isolates Obtained in Nanjing, China},
  author={Ming Zhang and Chun-lai Feng and Fei Chen and Qian He and Xin Su and Yi Shi},
  booktitle={Chinese medical journal},
  year={2017}
}
BACKGROUND During the past decades, the incidence of invasive aspergillosis (IA) caused by Aspergillus fumigatus has increased dramatically. The aims of this study were to investigate the susceptibility of clinical isolates of A. fumigatus to triazole and the underlying cyp51A mutations in triazole-resistant A. fumigatus. METHODS A total of 126 A. fumigatus clinical isolates from 126 patients with proven or probable IA were obtained from four large tertiary hospitals in Nanjing, China… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 19 REFERENCES

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2008
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009

JW van der Linden, E Snelders, +3 authors YJ Debets-Ossenkopp
  • Emerg Infect Dis 2011;17:1846-54. doi: 10.3201/eid1710.110226
  • 2011
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

EUCAST technical note on voriconazole and Aspergillus spp.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2013
VIEW 1 EXCERPT